Treatment News : Multivitamins: More Not Better When HIV Meds are Being Used

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » October 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

October 19, 2012

Multivitamins: More Not Better When HIV Meds are Being Used

More is not better when it comes to multivitamins combined with antiretroviral therapy, according to new data published in the Journal of the American Medical Association (JAMA). 

The results come from a Tanzanian study involving nearly 3,500 HIV-positive people starting antiretroviral therapy for the first time who were randomized to take either recommended daily allowance (standard-dose) multivitamins or high-dose multivitamins containing substantially higher concentrations of vitamins B, C and E.

Study volunteers receiving high-dose multivitamins were no less likely to progress to AIDS or die from any cause; CD4 cell gains and rates of undetectable viral loads were also no more pronounced among those receiving high-dose multivitamins. In fact, there was some evidence that severely malnourished individuals were more likely to die if they were receiving high-dose multivitamins. Levels of liver enzymes were also more likely to become seriously elevated among those receiving high-dose multivitamins, compared with standard-dose multivitamins, a finding that prompted the researchers to discontinue the study prematurely.  

Though previous studies concluded that high-dose multivitamins may help slow HIV disease progression and appeared safe among individuals unable to secure access to antiretroviral therapy, the researchers conclude that these new results underscore the need for adherence to standard-dose multivitamin recommendations when antiretroviral therapy is being used.

To read the JAMA report (paid subscription required), click here.

Search: multivitamin, tanzania, liver, alt, mortality, cd4 cells, viral load, jama


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (5 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.